Bob Lanier

Dr. Bobby Lanier was the 98th president to the Tarrant County Medical Society.  He is also Past President of the American College of Allergy Asthma and Immunology and distinguished fellow, and Past president of the Association of Certified Allergists, and the Texas Medical Association Foundation. Dr. Lanier is Board Certified by the American Board of Pediatrics, the Conjoint Board of Medicine and Pediatrics of Allergy Immunology, and the American Academy of Pharmaceutical Physicians and Association of Certified Research Professionals. Dr. Lanier serves on The Emerging Medical Societies taskforce and the Board of Directors for the World Allergy Association and travels extensively in that capacity. Dr. Lanier is a Clinical Professor at the University of North Texas Health Science Center, Texas College of Osteopathic Medicine. He has authored over 60 original contributions to the medical literature in peer reviewed journals, has written 2 textbook chapters in allergy and is active in the cutting edge of respiratory research through his firm North Texas Institute for Clinical Trials, being best known for his work on monoclonal anti-IgE. He has given over 100 presentations for Medical grand rounds in universities in this country, Europe, Asia, Australia, and South America in the last three years and is widely known for his dynamic, technologically advanced, and entertaining style.

Dr. Lanier and his wife Sandy and their two children arrived in Fort Worth in 1977 with the completion of military service.  Together they have worked to the benefit of people with AIDS and other community efforts. Dr. Lanier is the son of a union organizer and a school teacher who grew up in the refinery towns of south east Texas.  He experienced an extended childhood illness causing him to spend several years at John Sealy Hospital in Galveston where he would later attend medical school.  Home schooled because of his illness, Dr. Lanier attended public school full time first in the seventh grade, and eventually graduated as a co-valedictorian.   Dr. Lanier worked as a laboratory technician from high school through residency.  He attended Lamar University in Beaumont where he was recognized as a distinguished graduate, and the University of Texas Medical Branch in Galveston where he received his MD degree.

After a pediatric internship at UTMB, Dr. Lanier served in the Air Force and completed a Pediatric Residency at Wilford Hall USAF Medical Center in San Antonio.  He then was granted a civilian fellowship in Clinical Immunology at the Shrine Burns Institute in Galveston.   He returned to the Air Force to help set up the first training program in allergy and immunology where he continued until moving to Fort Worth in 1977.

Dr. Lanier founded Fort Worth Allergy and Asthma Associates in 1977 and continues in active practice at North Texas Institute for Clinical trials.   He sustains a practice for the indigent and non-insured community and as medical director of Lanier Education and Research Network, a corporation devoted to educational technology and pharmaceutical research.  Dr. Lanier founded the Society of Principal Investors, a professional society of physicians conducting FDA pharmaceutical trials. Since joining the medical society in 1977, Dr. Lanier has been involved intensely in communication efforts.  A medical society committee assignment in 1980 led to his involvement locally with the NBC television affiliate where he served in a public service capacity from 1981-2001. He has appeared on “Ophra”, several times on “Nightline with Ted Koppell”, the “Today Show ”,”Nightly News with Tom Brohaw”, “Good Morning America”, “Good Morning South Africa” and “Radio Zulu”. Dr. Lanier founded the National Association of Physician Broadcasters.   Dr. Lanier also served as an NBC television network correspondent from 1982-1985 after which time his television segments were internationally syndicated daily to over 100 television markets and heard in over 250 radio stations in this country and worldwide through the Armed Forces Radio and Television Network.  Dr. Lanier founded the National Association of Physician Broadcasters.  He was honored in 1995 by the American Medical Association with the Education and Research Foundations award for public communications.

Dr. Lanier stood for public office ( Congressional District 12) in 1989 and was defeated by Rep. Pete Geren . Dr. Lanier co-chaired the successful Congressional campaign of Representative Kay Granger.

Dr. Lanier is a passionate fisherman, photographer, and sports writer .His articles and photographs have appeared in in-flight and sports magazines.   He has written over 400 articles on sports fishing for magazines such as Saltwater Sportsman, Texas Parks and Wildlife and American Sportsman.   Dr. Lanier is also a computer programmer and currently served as a consultant for the American Medical Association for website development and computer related ethical issues. His hobby is technology – he is a die hard gadgeteer.

BOBBY QUENTIN LANIER, M.D.

6407 Southwest Boulevard Fort Worth, Texas 76132

CURRICULUM VITAE

Texas State Board of Medical Examiners Revised 10-2-2007

EDUCATION

· Undergraduate education: Lamar University (B.S. Biology, 1966)

· Professional education: University of Texas Medical Branch (M.D., 1966-1970)

· Post-graduate professional education:

Internship - University of Texas Medical Branch at Galveston

(Pediatrics, 1970-1971)

Residency - Wilford Hall USAF Medical Center

(Pediatrics, 1971-1973) Certification, 1975

Fellowship: University of Texas Medical Branch at Galveston

(Immunology 1973-1975) Certification, (1977)

· Certified Clinical Research Investigator: Association of Clinical Research Professionals (2002)

· Certified Clinical Research Investigator: Academy of Pharmaceutical Physicians (2004)

AWARDS

· Achievement Award, American Lung Association of Texas (2002)

· Bela Schick Lecture, American College of Allergy Asthma and Immunology 1996

· Distinguished Fellow, American College of Allergy Asthma and Immunology 1995

· American Medical Association, Education and Research Foundation Award

For Health Education (1994)

· Distinguished Alumni Lamar University (1994)

· Heart Association Paul R. Ellis Media Award (1990, 1994, 1998)

· Tarrant County Medical Association, Community Service Award (1987)

· Best Documentary “Cancer: Texas Strikes Back” Texas Cancer Society,(1987)

· Achievement of Excellence, documentary “Cancer: Texas Strikes Back”

Dallas Press Club (1987)

· American Academy of Family Physicians Active Teacher Award

(1980, 1981, 1982, 1983, 1984, 1985, 1986)

PROFESSIONAL EXPERIENCE

· Clinical Professor of Pediatrics: University of North Texas Health Science Center (present)

· Editorial Board Proceedings of Allergy Asthma and Immunology (2004 – present)

· Editor - American College of Allergy, Asthma and Immunology Symposia (2002)

· Editor – John Hopkins, Asthma Monitor (2001-2002)

· Medical Director- North Texas Institute for Clinical Trials: (1982-present)

· Founder and Executive Director- Medical Media Network: (1982-present)

· Private Practice- (1977- 1999)

· Founder: Fort Worth Allergy and Asthma Associates (1977)

· Chief / training director - Ped Allergy/Immunology, Wilford Hall USAF

Medical Center San Antonio, Texas (1975- 1977)

EXECUTIVE POSITIONS HELD

· Board of Directors, World Allergy Organization (2005- present)

· President – Association of Certified Allergists (2002-2003)

· President - American College of Allergy Asthma and Immunology (2001 – 2002)

· President: Texas Medical Association Foundation (2001- 2003)

· President: Tarrant County Medical Society (2000)

· Founder/EVP: Society of Principal Investigators (2000 – present)

· Board of Directors; Texas Medical Association Foundation (1998-present)

· Chairman: AllerDays Research Council for HMR (1997-1999)

· Chairman: Managed Care Council: American College of Allergy Asthma

and Immunology (1995-1996)

· President: Fort Worth Academy of Medicine ( 1994-1996)

· Treasurer: Tarrant County Medical Society ( 1994-1995)

· Founder and Executive Director: Academy of Radio and Television Health

Communicators (1990- present)

· Delegate (alt) American Medical Association American College of Allergy Asthma

and Immunology (1990-present)

· Board of Directors: Joint Council of Allergy and Immunology (1990-1995)

· Senior Vice President Harris Methodist Health System, Communications

Research (1989- 1998)

· Anchor / Editor: Medical Economics Video Magazine (1989 - 1995)

· Board of Regents, Executive Committee, American College Allergy and

Immunology (1989- 1995)

· Chairman: International Allergy Group for Scherring Corporation (1989-1993)

· President, National Association of Physician Broadcasters (1989-1991)

· Nominee for Congress, District 12 (1989)

· Chairman, Joint Marketing Task Force, American College Allergy and

Immunology (1987-1990)

· Chairman, Public Education Task Force on Cancer (1987)

· Founder, National Association of Physician Broadcasters (1986-1991)

· Medical Consultant, NBC News (1984-1986)

· Co-Chairman, Texas Legislative Task Force on Cancer (1984-1986)

· Chairman, Council on Communications, Texas Medical

Association (1984-1985)

· Medical Director, North Texas Institute for Clinical Trials, Fort Worth, Texas

(1982-Present)

· Founder/CEO - Bob Lanier, MultiMedia - (1982 - present) A medical communications and video corporation

· Medical Consultant, KXAS TV, (NBC) (1981 - 1998)

PROFESSIONAL ORGANIZATIONS

· World Allergy Organization (2001 – present)

· American Academy of General Physicians (1997-present)

· Alternate Delegate (American College of Allergy Asthma and Immunology)

American Medical Assoc., (1991- present)

· Society of Professional Journalists (1988-present)

· Radio & Television News Directors Association (1987-present)

· Board of Directors, American Lung Association (1984-1985)

· Tarrant County Medical Communication and Public Relations Committee (1981-1985)

· American Medical Association (1979-present)

· Texas Medical Association (1979-present)

· Tarrant County Pediatric Society (1979-present)

· Fellow, American College of Allergists (1979-present)

· Board of Directors, Tarrant County Medical Society (1979-1985)

· Board of Directors, Fort Worth Academy of Medicine (1978-1985)

· American Association of Certified Allergists (1977-present)

· Fellow, American Academy of Pediatrics (1977-present)

· Diplomat, American Board of Pediatrics (1975-present)

· Phi Beta Phi Medical Fraternity (1966-present)

TEACHING POSITIONS

· Clinical Professor of Pediatrics: University of North Texas Health Science Center (2003-2006)

· Faculty: Pilot program Scientific Communications fellowship World Allergy Organization (2006)

· Assistant Clinical Professor, Department of Medicine University of Texas Health

Science Center, Dallas TX - UTHSC Dallas (1979-2001)

· Faculty, American Medical Association - Annual Health Reporting

Conference (1982-1990)

· Supervisor: Clerkships for Family Practice Residents, John Peter Smith Hospital

Fort Worth, Texas (1980- 1988)

· Director Allergy division: Department of Family Practice, John Peter Smith Hospital,

Fort Worth, Texas (1979-1985)

· Attending physician: Division of Internal Medicine and Family Practice, Wilford Hall USAF Medical Center, San Antonio, Texas (1975-1977)

COMMUNITY ORGANIZATIONS

· Advisory Board of Directors, Samaritan Housing for AIDS (1997-present)

· Advisory Board, Tarrant County Harvest (1991- 1995)

· Advisory Board of Directors, AIDS Outreach Center (1990-present)

· Advisory Board Member, American Institute for Teen AIDS Prevention (1990-present)

· Spokesperson, Kid Care - Volunteer Connection, KXAS-TV (1990-1998)

· Finance and Executive Board, First United Methodist Church,

Fort Worth (1990- 1994)

· Board of Directors: Women with Aids (a childcare facility for the children of

families with AIDS) (1988)

· Board of Directors: University Place (Elderly Retirement Center and

Medical Facility) (1984-1998)

· Board of Directors, Salvation Army (1983-1987)

· Founder, Asthma Camp for Children, "Camp Huff 'n Puff" (1982-present)

· Board of Directors, Citizens Advisory Council for Cable Television (1981-1983)

· Board of Directors, Camp Carter-YMCA (1981-1983)

MEDIA EXPERIENCE

· Oprah, 1999, “Surviving a Hospital Stay”

· Talent: Schering Cable television half hour : Allergies - fact and myth ( 1995)

· Talent: Schering Cable television half hour: Allergies- how to survive (1995)

· Talent: "Medical Talk Etc..." KCBI Radio - weekly medical talk show (1991- 1993)

· Medical reporter - KCBI Radio (1990-present)

· Anchor: Medical Economics Video Magazine, a quarterly broadcast

and tape (1989-1995)

· Medical commentator - WBAP Radio (1985-2001)

· Talent, Writer, Producer: Sixty Second Housecall, daily national radio/television commentary in syndication (1985- 2001)

· Nightline Guest (ABC), Jan. 1985, "The Fate of Private Practice".

· Medical Reporter, KXAS TV, (NBC) (1981 - Present)

· NBC "A" News correspondent (1984-1986)

· Medical commentator - "Master Control", Southern Baptist Radio/TV

Commission (1984-1986)

· Nightline Guest (ABC), July 1984, "Controversies in Allergy".

· Medical commentator: Medical Portfolio - an audio cassette journal (1983-present)

· Talent, producer, writer: Glaxo- “Overview of Allergy (Introductory videotape)

· Talent, writer, producer: Glaxo- “Overview of Asthma (Introductory videotape)

· Talent, writer, producer: “Good news about heart attack treatment” 30 minute

broadcast documentary (1990)

BOOKS

· Textbook Chapter, Anti-IgE “Atlas of Allergy” Blaiss, Liberman 2005

· The Physician as Communicator - a text of communication skills for physicians.

· The New Epidemic: A Patient Survival Guide to Asthma (in progress)

· CD-ROM: Interactive Cases in Asthma (1995)

· CD-i Interactive Asthma Education Series

PUBLICATIONS

• Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH, Lanier BQ, Penna P; Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg. 2007 Jun;136(6 Suppl):S107-24.
• Lanier B; Allergic rhinitis: selective comparisons of the pharmaceutical options for management. Allergy Asthma Proc. 2007 Jan-Feb;28(1):16-9. Review.
• Lanier BQ: Epinastine 0.05% for the Treatment of Allergic Conjunctivitis, Expert Review of Opthamology, in press
• Liping, W, Yin,j Lanier,B   Baboon Syndrome Contact Dermatitis 56:356-357, 2007
• Lanier, Bob Q. Unanswered questions and speculations about the role of anti-immunologlobulin E in atopic and nonatopic disease , Allergy Asthma Proceedings Vol. 27, No. 2 March-April 2006, Supplement No.1
• Lanier, Bob Q. Unanswered Questions and Warnings Involving Anti–Immunoglobulin E Therapy Based on 2-Year Observation of Clinical Experience Proceedings of Allergy Asthma and ImmunologyVolume 26, Number 6, November-December 2005 pp. 435-439(5)
• Lanier BQ, Abstract:  Anaphylaxis with SIT while being treated with Xolair European Academy of Allergology and Clinical Immunology June 2005 Munich
• Lanier BQ, Abstract: " IgE does not consistently rise with anti-IgE therapy" presented at ACAAI annual meeting 2005 Nov 2005, Anaheim.
• Lanier BQ, Abstract: " IgE does not protect against anaphylaxis with SIT" presented at ACAAI annual meeting 2005 Nov.2005,  Anaheim.
• Lanier BQ, Abstract: " Safety and Efficacy of Olepatidine .6% Nasal spral in Perienial allergic rhinitis" presented at AAAAI annual meeting 2006, March 2006 Miami

• Lanier BQ, Allergy- On The Rise and in the News, Refractive Eyecare Feb 2006 V10 Number 2
• Lanier BQ, Hampel F, Kittner B, Varghese ST, Safety Of Fexofenadine In Pre-School Children With Allergic Rhinitis, Abstract, American Academy of Pediatics, 2005 National Confernece and Exhibition  October 2005, Washington, D.C.
• BQ Lanier, Editorial Board: Allergy and Asthma Proceedings, (under academic appointments)

• G.Shapiro, G. Bensch R. Lanier, L. Sher M. Lloyd, S. Kundu, J. Williams, D. Banerji, Once-daily treatment with ciclesonide is effective and well tolerated in children with persistent asthma, Abstract, annual meeting AAAAI, 2005 San Antonio, Texas
• Lanier BQ, Miller D, Omalizumab is well tolerated in adolescent/adult patients(>=12 years) with moderate-to-severe persistent asthma, Abstract presented at ATS Meeting, May 2005
• Lanier BQ, Casale TB, Omalizumab is well tolerated in adolescent/adult patients(>=12 years) with moderate-to-severe persistent asthma, Abstract presented at AAAI Annual Meeting, March 2005
• Lanier BQ, textbook chapter, Blaiss Atlas of Allergy and Immunology – in press
• Lanier BQ, textbook chapter, Leiberman and Anderson, Allergy and Immunology – in press

• Lanier BQ, Chang TW, Will Anti-IgE therapt Comprimise Normal Immune Functions?, Allergy & Clinical Immunology International, Nov/Dec 2004
• Lanier BQ, Carr W, Omalizumab in the Treatment of Allergy and Asthma, Drug profile, Therapy 2004 1(1)25-30
• Lanier BQ, Finegold I, D’Arienzo PA, Clinical Effecacy of Olopatadine vs epinsatine ophthalmic solution in the conjunctival allergen challenge Model, Current Medical Research, Aug 2004
• Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.J Allergy Clin Immunol. 2004 May;113(5):832-6.
• Lanier, BQ, Marshall GD Jr, Unanswered questions on Omalzumab (Xolair) patient Selection and Follow-up, Ann Allergy Asthma Immunol, Feb 2004

• Lanier, BQ, Analysis of the Efficacy of Technical Presentations As a Means of Sharing Data and Modifying Behavior of Professionals, Xolair Source, Jan 2004
• Roland PS, Kreisler LS, Reese B, Anon JB, Lanier BQ, et al, Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.Pediatrics. 2004 Jan;113(1 Pt 1)
• Lanier BQ, Patient education doesn’t work-“edu-tainment” does, Annals of Allergy

Aug 2003

• Lanier BQ, Corren J, Lumry W, Liu J, Fowler-Taylor AR, Gupta N, Omalizumab is Effective in the Long-Term Control of Severe Allergic Asthma, Annals of Allergy

Aug 2003

• Lanier, BQ, Newer aspects in the treatment of pediatric and adult asthma: monoclonal anti-IgE, Ann Allergy Asthma Immunol. 2003 Jun;90(6 Suppl 3):13-5. Review.
• Lanier BQ, Ableson MB, Berger WE, Granet DB, D’Arienzo PA, Spanlger DL, Kagi MK, Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge, Clinical Therapeutics, Jul 2002
• Finegold I, Lanier BQ, Berger W, Blaiss M, Immunotherapy for asthma, Am J Respir Crit Care Med, May 2002, 15;165(10):1453-4.
• Lanier BQ, Anti-IgE in the real world, Editorial, Annals of Allergy, May 2002
• Lanier BQ, Busse W, Corren J, Liu J, Fowler-Taylor AR, Gupta N, Omalizumab is Effective in the Long-Term Control of Severe Allergic Asthma, Submitted JAMA, 2002
• Weinstein SF(a), Welch MJ, Lanier BQ, Nayak A, Stampone P, New Beclomethasone Diporionate Extrafine Aerosol is Effective Pediatric Asthma Therapy, Abstract, 58^th Annual Meeting of the American Academy of Allergy Asthma and Immunology, New York, USA, March 01-06, 2002
• Lanier BQ, When the whole is more than the sum of it’s parts, Annals of Allergy, Asthma, and Immunology, Dec 2001; 87(6): 445-6.
• Busse W, Coren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, Van As A, Gupta N, Omalizumab, Anti-IgE Recombinant Humanized Monoclonal Antibody, for the Treatment of Severe Allergic Asthma, J Allergy Clin Immunol, Aug 2001

108(2):184-90

• Lanier BQ, No Prescription Needed –No Doctor Either, Annals of Allergy, Asthma & Immunology, Jul 2001, 87 (1) p1-2, editorial
• Lanier BQ, New Treatments and the Future Role of Immunotherapy: Anti-IgE, Annals of Allergy, Asthma & Immunology: Official Publication of the American College of Allergy, Asthma & Immunology Jul 2001, 87 (1 suppl 1) p68-9
• Lanier BQ, Gross R D, Marks B, Cockrum PC, Juniper EF, Olopatadine Ophthalmic Solution Adjunctive to Loratadine Compared to Loratadine Alone in Patients With Active Seasonal Allergic Conjunctivitis Symptoms, Annals of Allergy, Asthma, and Immunology, 2001 Jun; 86(6):641-8.
• Lanier BQ, Berger WE, D’Arienzo P, Granet D, Comparison of the Safety and Efficacy of the Concomitant Use of Flonase® (Fluticasone propionate 5 mcg/aqueous nasal spray) and Patanol® (olopatadine HCl 0.1% ophthalmic solution) versus Allegra® (Fexofenadine HCl 60 mg capsule and Flonase® (Fluticasone propionate 50 mcg/aqueous nasal spray) versus placebo in subjects with allergic rhinoconjunctivitis in the conjunctival allergen challenge (CAC) model In press, Clinical theraputics
• Tillinghast J(a), Lanier BQ, Busse W, Chervinsky P, Ashby M, Fowler-Taylor A, Fick R, Gupta N, Omalizumab Significantly Increases Time to First Asthma Exacerbation Compared with Placebo, XXth Congress of the European Academy of Allenology and Clinical Immunology Berlin, Germany May 09-13 2001
• Lumry W(a), Berger W, Corren J, Lanier BQ, Busse W, Chervinsky P, Nayak A , Fowler-Taylor A, Fick R, Gupta N, Evidence of the Long-term Safety and Tollerability of Omalizmab from a Large Phase III Study, , XXth Congress of the European Academy of Allenology and Clinical Immunology Berlin, Germany May 09-13 2001
• Nelson H, Fick R, Fowler-Taylor A, Ashby M, Busse W, Chervinsky P, Lanier BQ, Gupta N, Corren J, Rohane P, Increased Time to First Asthma Exacerbation Seen in Xolair Treated Patients Compared with Placebo, Ann. Allergy Asthma Immunol. 86, No.1 98, 2001
• Berger W, Nayak A, Fowler-Taylor A, Chervinsky P, Busse W, Lanier BQ, Corren J, Gupta N, Rohane P, Fick R, Long-term Safety and Tolerability of Xolair–A Double Blind, Placebo–Controlled Study, Ann. Allergy Asthma Immunol. 886, NO.1 , 97, 2001
• Lanier BQ, Fowler-Taylor A, gupta W, McAlary M, Corren J, Matz J, Townley R, Fick R, Rohane P, Effect of Severity of Disease on the Efficacy of Xolair – Results from Two Double-Blind, Placebo-Controlled Studies, Ann. Allergy Asthma Immunol. 86 No. 1, 82, 2001
• Busse W, Corren J, Lanier BQ, Everhard F, Surrey K, Kirchdorfer L, Omalizumab Improves Asthma-specific Quality Of Life (QoL): A